Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
Clinical trial NCT05595460 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05595460
- Sponsor
- RayzeBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2027-07-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.